ProPublica: Medicare could save billions with generic drugs

NewsGuard 100/100 Score

The nonprofit news service analyzed millions of prescriptions. Also, a CMS official says "the Medicare program is stronger today than in recent memory."

ProPublica: Medicare's Failure to Track Doctors Wastes Billions on Name-Brand Drugs
Medicare is wasting hundreds of millions of dollars a year by failing to rein in doctors who routinely give patients pricey name-brand drugs when cheaper generic alternatives are available. ProPublica analyzed the prescribing habits of 1.6 million practitioners nationwide and found that a tiny fraction of them are having an outsized impact on spending in Medicare's massive drug program (Ornstein, Weber and LaFleur, 11/18).

Georgia Health News: Who Likes The ACA? Top Medicare Official Says Law Is Boon For Seniors
Recent problems with the Affordable Care Act -- a poorly functioning insurance exchange website and an uproar over canceled policies -- have dominated headlines and reignited political debates. But Jonathan Blum has a positive message to deliver about the ACA and its effect on the Medicare program, which covers about 1.4 million Georgians (Miller,11/18).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research sheds light on how GLP-1 obesity drugs may change food cravings